EPHX2 and amyotrophic lateral sclerosis: CID 139587415 (PUBCHEM_CID: 139587415) targeted ETFB and EPHX2 in ALS (Importance 27.5) and MS (Importance 15.1), with a combined importance of 42.6, highlighting mitochondrial lipid metabolism and detoxification pathways.